Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01130896 · ClinicalTrials.gov registry record
Clinically Indicated Magnetic Resonance Imaging in Patients With Cardiac Devices
A clinical trial, sponsored by Johns Hopkins University.
- Completed
- Registry status
- 1,509
- Enrollment target
NCT01130896: Completed study, sponsored by Johns Hopkins University.
NCT01130896 is a clinical trial that has completed, run by Johns Hopkins University. The registered enrollment target is 1,509 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01130896 has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- 1,509 participants
- Enrollment target
Study Summary
Patients with implanted cardiac devices who meet appropriate entrance criteria undergo clinically indicated Magnetic Resonance (MR) Imaging Studies using an established safety protocol.
Primary Outcome
Number of patients with change in device testing defined as a change in any of the following (impedance, battery life, p and r wave sensing and atrial and ventricular capture thresholds) not to exceed 50 percent from baseline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,509 participants |
| Start Date | 2003-05 |
| Est. Completion | 2015-01-22 |
What the finished NCT01130896 record still lists
NCT01130896 is an observational study that tracks outcomes without assigning an intervention. Its 1,509 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT01130896 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01130896 about?
NCT01130896 is a clinical study titled "Clinically Indicated Magnetic Resonance Imaging in Patients With Cardiac Devices". Patients with implanted cardiac devices who meet appropriate entrance criteria undergo clinically indicated Magnetic Resonance (MR) Imaging Studies using an established safety protocol.
What is the current status of trial NCT01130896?
This trial is currently completed. The enrollment target is 1,509 participants. The study started on 2003-05. Estimated completion is 2015-01-22.
Who is sponsoring clinical trial NCT01130896?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07136623 · 1,513 participants
Detecting Pulmonary Hypertension With the Eko CORE 500 Digital Stethoscope
- NCT05633654 · 1,514 participants · Phase 3
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
- NCT00178724 · 1,500 participants
Spinal Cord Injury Registry - North American Clinical Trials Network
- NCT00951366 · 1,500 participants
Preterm Lung Patient Registry
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia